AYTU BioPharma, Inc. (AYTU) Dividend History
AYTU BioPharma, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of therapies for rare and specialty conditions. The company markets oral formulations of testosterone and other hormone-based treatments, aiming to address hormonal deficiencies and related health issues. Founded with a focus on innovation in hormone therapy, AYTU aims to expand its product offerings and pipeline to serve underserved patient populations.
Dividend History
AYTU BioPharma, Inc. currently does not pay dividends
Company News
-
The 73rd Emerging Growth Conference is scheduled for July 17-18, 2024, featuring presentations from various companies in the healthcare, technology, and energy sectors.
GlobeNewswire Inc. -
Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results. Shapeways Hldgs posted an adjusted loss of $1.36 per share, versus market expectations for a loss of 95 cents per share. The company’s quarterly sales came in at $8.37 million versus estimates of $8.75 million. Shapeways shares fell 20.8% to $2.36 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) shares climbed 62.4% to $2.16 after the company reported third-quarter results. Chemomab Therapeutics Ltd. (NASDAQ: CMMB) shares jumped 55% to $0.9497 after the FDA granted CM-101 Fast Track designation for adult patients of primary sclerosing cholangitis (PSC), a fibrotic liver disease. Heron Therapeutics, Inc. (NASDAQ: HRTX) climbed 50.8% to $0.8143 after the company reported mixed third-quarter financial results and issued guidance. Kinnate Biopharma Inc. (NASDAQ: KNTE) rose 47.7% to $2.32. The company’s board of directors received a letter from Foresite Capital Management and OrbiMed Advisors indicating their intent to explore and evaluate a potential acquisition of the company. SciSparc Ltd. (NASDAQ: SPRC) gained 44.5% to $6.30. SciSparc said 'trial results indicated that SciSparc's proprietary SCI-110 provided a safe and effective solution for alleviating agitation in elderly Alzheimer's patients who participated.' Evelo Biosciences, Inc. (NASDAQ: EVLO) gained 36% to $0.47. Babcock & Wilcox Enterprises, Inc. (NYSE: BW) climbed 34.3% to $1.75. Solid Biosciences Inc. (NASDAQ: SLDB) shares rose 32.7% to $2.83. Solid Biosciences announced IND clearance by the FDA for duchenne muscular dystrophy gene therapy candidate SGT-003. MGO Global, Inc. (NASDAQ: MGOL) shares climbed 32.4% to $0.6566 after reporting a sharp rise in third-quarter sales. Beyond Air, Inc. (NASDAQ: XAIR) gained 28% to $1.7920. AST SpaceMobile, Inc. (NASDAQ: ASTS) rose 28% to $4.8262 following third-quarter results. Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares climbed 25.2% to $24.34 after the company reported a ...
Benzinga -
Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks. Baudax Bio, Inc. (NASDAQ: BXRX) gained 109% to $0.6287 after the company announced it was granted orphan drug designation by the FDA for TI-168 for the treatment of Hemophilia A with inhibitors. Chico's FAS, Inc. (NYSE: CHS) shares climbed 61.7% to $7.45 following the announcement of its acquisition by Sycamore Partners for $1 billion. Aditxt, Inc. (NASDAQ: ADTX) gained 57% to $20.47. Axcella Health Inc. (NASDAQ: AXLA) rose 31.3% to $9.08. Inpixon (NASDAQ: INPX) shares gained 23.6% to $0.1729 after gaining around 10% on Wednesday. Soleno Therapeutics, Inc. (NASDAQ: SLNO) jumped 22.2% to $25.25. Soleno Therapeutics reported pricing of approximately $120 million underwritten public offering of common stock and concurrent private placement of common stock and/or pre-funded warrants. Aytu BioPharma, Inc. (NASDAQ: AYTU) gained 22% to $2.33 following fourth-quarter results. Organogenesis Holdings Inc. (NASDAQ: ORGO) gained 20.4% to $3.19. Sarcos Technology and Robotics Corporation (NASDAQ: STRC) gained 20% to $0.80 after the company announced it was awarded a $13.8 million USD contract by the U.S. Air Force for the advancement of its AI and machine learning software. Adamas One Corp. (NASDAQ: JEWL) gained 18% to $0.9200. USA Compression Partners, LP (NYSE: USAC) climbed 14.7% to $25.94. Gritstone bio, Inc. (NASDAQ: GRTS) gained 14.2% to $1.36. Connexa Sports Technologies Inc. (NASDAQ: CNXA) gained 13.7% to $4.08. Connexa Sports Technologies recently announced that it received a letter from the Nasdaq regarding the late filing of its quarterly report. VinFast Auto Ltd. (NASDAQ: VFS) climbed 13.6% to $12.73 following a report suggesting the company is planning to set up a manufacturing plant in India. Gritstone bio, Inc. (NASDAQ: GRTS) shares rose 13.5% to $1.3550 after the company announced it was awarded a BARDA contract to conduct a Phase 2b comparative study evaluating a next-generation vaccine candidate for COVID-19 valued at ...
Benzinga -
Best penny stocks to buy? 4 with news to watch this week The post Best Penny Stocks? 4 Hot Stocks With News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
PennyStocks -
Upgrades According to B. Riley Securities, the prior rating for Mirati Therapeutics Inc (NASDAQ:MRTX) was changed from Neutral to Buy. In the second quarter, Mirati Therapeutics showed an EPS of $3.04, compared to $3.18 from the year-ago quarter. The stock has a 52-week-high of $101.20 and a 52-week-low of $27.30. At the end of the last trading period, Mirati Therapeutics closed at $27.80. B. Riley Securities upgraded the previous rating for Novavax Inc (NASDAQ:NVAX) from Neutral to Buy. In the second quarter, Novavax showed an EPS of $0.58, compared to $6.53 from the year-ago quarter. At the moment, the stock has a 52-week-high of $62.74 and a 52-week-low of $5.61. Novavax closed at $7.23 at the end of the last trading period. WestPark Capital upgraded the previous rating for WM Technology Inc (NASDAQ:MAPS) from Hold to Buy. WM Tech earned $0.01 in the second quarter, compared to $0.13 in the year-ago quarter. At the moment, the stock has a 52-week-high of $3.62 and a 52-week-low of $0.60. WM Tech closed at $1.20 at the end of the last trading period. Berenberg upgraded the previous rating for Marqeta Inc (NASDAQ:MQ) from Hold to Buy. For the second quarter, Marqeta had an EPS of $0.11, compared to year-ago quarter EPS of $0.08. The stock has a 52-week-high of $11.28 and a 52-week-low of $3.46. At the end of the last trading period, Marqeta closed at $4.96. For Chart Industries Inc (NYSE:GTLS), Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. Chart Industries earned $1.19 in the second quarter, compared to $0.88 in the year-ago quarter. The current stock performance of Chart Industries shows a 52-week-high of $242.00 and a 52-week-low of $101.44. Moreover, at the end of the last trading period, the closing price was at $165.76. For Golub Capital BDC Inc (NASDAQ:GBDC), Raymond James upgraded the previous rating of Market Perform to Outperform. Golub Capital BDC earned $0.44 in the third quarter, compared to $0.31 in the year-ago quarter. The current stock performance of Golub Capital BDC shows a 52-week-high of $14.50 and a 52-week-low of $11.95. Moreover, at the end of the last trading period, the closing price was at $14.38. According to JP Morgan, the prior rating for DraftKings Inc (NASDAQ:DKNG) was changed from Underweight to Neutral. In the second quarter, DraftKings showed an EPS of $0.14, compared to $0.29 from the year-ago quarter. The stock has a 52-week-high of $34.49 and a 52-week-low of $10.70. At the end of the last trading period, DraftKings closed at $31.71. According to Roth MKM, the prior rating for LivePerson Inc (NASDAQ:LPSN) was changed from Neutral to Buy. For the second quarter, LivePerson had an EPS of $0.12, compared to year-ago quarter EPS of $0.98. At the moment, the stock has a 52-week-high of $18.17 and a 52-week-low of $3.19. LivePerson closed at $3.99 at the end of the last trading period. For Equinor ASA (NYSE:EQNR), RBC Capital upgraded the previous rating of Sector Perform to Outperform. Equinor earned $0.73 in the second quarter, compared to $1.56 in the year-ago quarter. The current stock performance of Equinor shows a 52-week-high of $42.53 and a 52-week-low of $25.23. Moreover, at the end of the last trading period, the closing price was at $30.86. According to Jefferies, the prior rating for Eli Lilly and Co (NYSE:LLY) was changed from Hold to Buy. For the second quarter, Eli Lilly had an EPS of $2.11, compared to year-ago quarter EPS of $1.25. The current stock performance of Eli Lilly shows a 52-week-high of $538.00 and a 52-week-low of $296.34. Moreover, at the end of the last trading period, the closing price was at $521.60. According to Barclays, the prior rating for DISH Network Corp (NASDAQ:DISH) was changed from Underweight to Equal-Weight. In the second quarter, DISH Network showed an EPS of $0.31, compared to $0.82 from the year-ago quarter. The current stock performance of DISH Network shows a 52-week-high of $20.35 and a 52-week-low of $5.83. Moreover, at the end of the last trading period, the closing price was at $8.37. See all analyst ratings upgrades. Downgrades RBC Capital downgraded the previous rating for Calamos Global Dynamic Income Fund (NASDAQ:CHW) from Sector Perform to Underperform. The stock has a 52-week-high of $7.87 and a 52-week-low of $5.33. At the end of the last trading period, Calamos Glb Dynamic closed at $6.09. According to HC Wainwright & Co., the prior rating for Decibel Therapeutics Inc (NASDAQ:DBTX) was changed from Buy to Neutral. For the first quarter, Decibel Therapeutics had an EPS of $0.53, compared to year-ago quarter EPS of $0.56. The current stock performance of Decibel Therapeutics shows a 52-week-high of $5.68 and a 52-week-low of $1.61. Moreover, at the end of the last trading period, the closing price was at $2.79. Northland Capital Markets downgraded the previous rating for Vitesse Energy Inc (NYSE:VTS) from Outperform to Market Perform. Vitesse Energy earned $0.35 in the second quarter, compared to $0.04 in the year-ago quarter. At the moment, the stock has a 52-week-high of $27.39 and a 52-week-low of $13.90. Vitesse Energy closed at $24.81 at the end of the last trading period. According to BTIG, the prior rating for WeWork Inc (NYSE:WE) was changed from Buy to Neutral. For the second quarter, WeWork had an EPS of $0.21, compared to year-ago quarter EPS of $0.76. At the moment, the stock has a 52-week-high of $5.93 and a 52-week-low of $0.16. WeWork closed at $0.21 at the end of the last trading period. According to Macquarie, the prior rating for PubMatic Inc (NASDAQ:PUBM) was changed from Outperform ...Full story available on Benzinga.com
Benzinga